Urografin 150 Side Effects
Generic name: diatrizoate
Medically reviewed by Drugs.com. Last updated on Sep 7, 2022.
Note: This document contains side effect information about diatrizoate. Some dosage forms listed on this page may not apply to the brand name Urografin 150.
Applies to diatrizoate: intravenous solution.
Serious side effects of Urografin 150
Along with its needed effects, diatrizoate (the active ingredient contained in Urografin 150) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking diatrizoate:
Incidence not known
- Blood in the urine
- decrease in the amount of urine
- difficulty with swallowing
- fast heartbeat
- hives, itching, or rash
- not able to pass urine
- pain or burning while urinating
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- shortness of breath
- tightness in the chest
- unusual tiredness or weakness
For Healthcare Professionals
Applies to diatrizoate: injectable powder for injection, injectable solution, oral powder for reconstitution, oral and rectal solution.
Common (1% to 10%) Transient disturbance in heart rate, blood pressure, disturbance in cardiac rhythm or function, cardiac arrest
Uncommon (0.1% to 1%): Thrombophlebitis, venous thrombosis
Rare (0.01% to 0.1%): Thromboembolic events, myocardial infarction
Common (1% to 10%): Nausea, vomit, diarrhea
Frequency not reported: Diarrhea (ceases as soon as the intestine has been emptied); existing enteritis or colitis may be temporarily exacerbated; in case of obstruction, the prolonged contact with bowel mucosa can lead to erosions and to bowel necrosis; intestinal perforation; abdominal pain; oral mucosal blistering[Ref]
Common (1% to 10%): Transient disturbances in respiratory rate, dyspnea, respiratory distress, cough
Rare (less than 0.1%): Respiratory arrest, pulmonary edema
Uncommon (0.1% to 1%): Thyroid function tests indicative of hypothyroidism or transient thyroid suppression in adults and pediatric patients (including infants)
Frequency not reported: Sweating, mild angioedema[Ref]
Very rare (less than 0.01%): Convulsions, cerebral symptoms
Frequency not reported: Disturbances in consciousness, dizziness, headache, tremor, somnolence, transient paresis (vision or facial muscle paresis and epileptic fits), amnesia, photophobia, temporary states of agitation or confusion[Ref]
Frequency not reported: Local pain, edema[Ref]
Frequency not reported: Fluid and electrolyte imbalance[Ref]
Frequency not reported: Lacrimation, temporary blindness[Ref]
Frequency not reported: Pyrexia, sweating, chills, blanching, weakness, gagging and feeling suffocated, gasping, edema, cramp, malaise[Ref]
Frequency not reported: Temporary renal failure[Ref]
More about Urografin 150 (diatrizoate)
Related treatment guides
1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
2. Cerner Multum, Inc. "Australian Product Information." O 0
Some side effects may not be reported. You may report them to the FDA.